A second independent locus within DMRT1 is associated with testicular germ cell tumor susceptibility

Human Molecular Genetics

Volumn 20, Issue 15, 2011, Pages 3109-3117

  Kanetsky, Peter A ^a,b   Mitra, Nandita ^a,b   Vardhanabhuti, Saran ^a   Vaughn, David J ^a,b   Li, Mingyao ^a   Ciosek, Stephanie L ^a   Letrero, Richard ^a   D'Andrea, Kurt ^a   Vaddi, Madhavi ^a   Doody, David R ^c   Weaver, JoEllen ^d   Chen, Chu ^c,f   Starr, Jacqueline R ^c,f   Håkonarson, Håkon ^e   Rader, Daniel J ^a   Godwin, Andrew K ^g   Reilly, Muredach P ^a   Schwartz, Stephen M ^c,f   Nathanson, Katherine L ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

^d FOX CHASE CANCER CENTER   (United States)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATF7IP PROTEIN; BAK1 PROTEIN; KITLG PROTEIN; PROTEIN; SPRY4 PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DMRT1; UNCLASSIFIED DRUG;

ADULT; ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GERM CELL TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; NON SEMINOMATOUS GERMINOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TESTIS TUMOR;

ADOLESCENT; ADULT; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; TESTICULAR NEOPLASMS; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 79960130481     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddr207     Document Type: Article

References (53)

1. Altekruse, S., Kosary, C., Krapcho, M., Neyman, N., Aminou, R., Waldron, W., Ruhl, J., Howlader, N., Tatalovich, Z., Cho, H. et al. (2010). National Cancer Institute, Bethesda, MD, http://seer.cancer.gov/csr/1975_2007/, based on November 2009 SEER data submission, posted to the SEER web ite, 2010.
2. Huyghe, E., Matsuda, T. and Thonneau, P. (2003) Increasing incidence of testicular cancer worldwide: a review. J. Urol., 170, 5-11.
3. Curado, M.P., Edwards, B., Shin, H.R., Ferlay, J., Heanue, M. and Boyle, P. (eds) (2007). Cancer incidence in five continents, Vol. IX. International Agency for Research on Cancer, Lyon, France.
4. The International Testicular Cancer Linkage Consortium (1998) Candidate regions for testicular cancer susceptibility genes. APMIS, 106, 64-70; discussion 71-62.
5. Raven, R.W. (1934) Tumours of the testics in two brothers. Lancet, 2, 870-871.
6. Bromen, K., Stang, A., Baumgardt-Elms, C., Stegmaier, C., Ahrens, W., Metz, K.A. and Jockel, K.H. (2004) Testicular, other genital, and breast cancers in first-degree relatives of testicular cancer patients and controls. Cancer Epidemiol. Biomarkers Prev., 13, 1316-1324.
7. Chia, V.M., Li, Y., Goldin, L.R., Graubard, B.I., Greene, M.H., Korde, L., Rubertone, M.V., Erickson, R.L. and McGlynn, K.A. (2009) Risk of cancer in first- and second-degree relatives of testicular germ cell tumor cases and controls. Int. J. Cancer, 124, 952-957.
8. Forman, D., Oliver, R.T., Brett, A.R., Marsh, S.G., Moses, J.H., Bodmer, J.G., Chilvers, C.E. and Pike, M.C. (1992) Familial testicular cancer: a report of the UK family register, estimation of risk and an HLA class 1 sib-pair analysis. Br. J. Cancer, 65, 255-262.
9. Gundy, S., Babosa, M., Baki, M. and Bodrogi, I. (2004) Increased predisposition to cancer in brothers and offspring of testicular tumor patients. Pathol. ncol. Res., 10, 197-203.
10. Heimdal, K., Olsson, H., Tretli, S., Flodgren, P., Borresen, A.L. and Fossa, S.D. (1996) Familial testicular cancer in Norway and southern Sweden. Br. J. Cancer, 73, 964-969.
11. Hemminki, K. and Chen, B. (2006) Familial risks in testicular cancer as aetiological clues. Int. J. Androl., 29, 205-210.
12. Sonneveld, D.J., Sleijfer, D.T., Schrafford Koops, H., Sijmons, R.H., van der Graaf, W.T., Sluiter, W.J. and Hoekstra, H.J. (1999) Familial testicular cancer in a single-centre population. Eur. J. Cancer, 35, 1368-1373.
13. Spermon, J.R., Witjes, J.A., Nap, M. and Kiemeney, L.A. (2001) Cancer incidence in relatives of patients with testicular cancer in the eastern part of the Netherlands. Urology, 57, 747-752.
14. Westergaard, T., Olsen, J.H., Frisch, M., Kroman, N., Nielsen, J.W. and Melbye, M. (1996) Cancer risk in fathers and brothers of testicular cancer patients in Denmark. A population-based study. Int. J. Cancer, 66, 627-631.
15. Neale, R.E., Carriere, P., Murphy, M.F. and Baade, P.D. (2008) Testicular cancer in twins: a meta-analysis. Br. J. Cancer, 98, 171-173.
16. Swerdlow, A.J., De Stavola, B.L., Swanwick, M.A., Mangtani, P. and Maconochie, N.E. (1999) Risk factors for testicular cancer: a case-control study in twins. Br. J. Cancer, 80, 1098-1102.
17. Czene, K., Lichtenstein, P. and Hemminki, K. (2002) Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int. J. Cancer, 99, 260-266.
18. Kanetsky, P.A., Mitra, N., Vardhanabhuti, S., Li, M., Vaughn, D.J., Letrero, R., Ciosek, S.L., Doody, D.R., Smith, L.M., Weaver, J. et al. (2009) Common variation in KITLG and at 5q31.3 predisposes to testicular germ cell cancer. Nat. Genet., 41, 811-815.
19. Rapley, E.A., Turnbull, C., Al Olama, A.A., Dermitzakis, E.T., Linger, R., Huddart, R.A., Renwick, A., Hughes, D., Hines, S., Seal, S. et al. (2009) A genome-wide association study of testicular germ cell tumor. Nat. Genet., 41, 807-810.
20. Turnbull, C., Rapley, E.A., Seal, S., Pernet, D., Renwick, A., Hughes, D., Ricketts, M., Linger, R., Nsengimana, J., Deloukas, P. et al. (2010) Variants near DMRT1, TERT and ATF7IP are associated with testicular germ cell cancer. Nat. Genet., 42, 604-607.
21. Bacanu, S.A., Devlin, B. and Roeder, K. (2000) The power of genomic control. Am. J. Hum. Genet., 66, 1933-1944.
22. Dadd, T., Weale, M.E. and Lewis, C.M. (2009) A critical evaluation of genomic control methods for genetic association studies. Genet. Epidemiol., 33, 290-298.
23. Koopman, P. (2009) Sex determination: the power of DMRT1. Trends Genet., 25, 479-481.
24. Kim, S., Bardwell, V.J. and Zarkower, D. (2007) Cell type-autonomous and non-autonomous requirements for Dmrt1 in postnatal testis differentiation. Dev. Biol., 307, 314-327.
25. Raymond, C.S., Murphy, M.W., O'Sullivan, M.G., Bardwell, V.J. and Zarkower, D. (2000) Dmrt1, a gene related to worm and fly sexual regulators, is required for mammalian testis differentiation. Genes Dev., 14, 2587-2595.
26. Calvari, V., Bertini, V., De Grandi, A., Peverali, G., Zuffardi, O., Ferguson-Smith, M., Knudtzon, J., Camerino, G., Borsani, G. and Guioli, S. (2000) A new submicroscopic deletion that refines the 9p region for sex reversal. Genomics, 65, 203-212.
27. Livadas, S., Mavrou, A., Sofocleous, C., van Vliet-Constantinidou, C., Dracopoulou, M. and Dacou-Voutetakis, C. (2003) Gonadoblastoma in a patient with del(9)(p22) and sex reversal: report of a case and review of the literature. Cancer Genet. Cytogenet., 143, 174-177.
28. Fahrioglu, U., Murphy, M.W., Zarkower, D. and Bardwell, V.J. (2007) mRNA expression analysis and the molecular basis of neonatal testis defects in Dmrt1 mutant mice. Sex. Dev., 1, 42-58.
29. Krentz, A.D., Murphy, M.W., Kim, S., Cook, M.S., Capel, B., Zhu, R., Matin, A., Sarver, A.L., Parker, K.L., Griswold, M.D. et al. (2009) The DM domain protein DMRT1 is a dose-sensitive regulator of fetal germ cell proliferation and pluripotency. Proc. Natl Acad. Sci. USA, 106, 22323-22328.
30. Almstrup, K., Hoei-Hansen, C.E., Wirkner, U., Blake, J., Schwager, C., Ansorge, W., Nielsen, J.E., Skakkebaek, N.E., Rajpert-De Meyts, E. and Leffers, H. (2004) Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res., 64, 4736-4743.
31. Hoei-Hansen, C.E., Nielsen, J.E., Almstrup, K., Hansen, M.A., Skakkebaek, N.E., Rajpert-DeMeyts, E. and Leffers, H. (2004) Identification of genes differentially expressed in testes containing carcinoma in situ. Mol. Hum. Reprod., 10, 423-431.
32. Rajpert-De Meyts, E., Bartkova, J., Samson, M., Hoei-Hansen, C.E., Frydelund-Larsen, L., Bartek, J. and Skakkebaek, N.E. (2003) The emerging phenotype of the testicular carcinoma in situ germ cell. APMIS, 111, 267-278; discussion 278-269.
33. van Gurp, R.J., Oosterhuis, J.W., Kalscheuer, V., Mariman, E.C. and Looijenga, L.H. (1994) Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. J. Natl Cancer Inst., 86, 1070-1075.
34. Hersmus, R., de Leeuw, B.H., Wolffenbuttel, K.P., Drop, S.L., Oosterhuis, J.W., Cools, M. and Looijenga, L.H. (2008) New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD). Mol. Cell Endocrinol., 291, 1-10.
35. Doria-Rose, V.P., Biggs, M.L. and Weiss, N.S. (2005) Subfertility and the risk of testicular germ cell tumors (United States). Cancer Causes Control, 16, 651-656.
36. Peng, X., Zeng, X., Peng, S., Deng, D. and Zhang, J. (2009) The association risk of male subfertility and testicular cancer: a systematic review. PLoS ONE, 4, e5591.
37. Richiardi, L. and Akre, O. (2005) Fertility among brothers of patients with testicular cancer. Cancer Epidemiol. Biomarkers Prev., 14, 2557-2562.
38. Richiardi, L., Akre, O., Montgomery, S.M., Lambe, M., Kvist, U. and Ekbom, A. (2004) Fecundity and twinning rates as measures of fertility before diagnosis of germ-cell testicular cancer. J. Natl Cancer Inst., 96, 145-147.
39. Walsh, T.J., Croughan, M.S., Schembri, M., Chan, J.M. and Turek, P.J. (2009) Increased risk of testicular germ cell cancer among infertile men. Arch. Intern. Med., 169, 351-356.
40. Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Soc. Stat. Soc. B, 57, 289-300.
41. Skol, A.D., Scott, L.J., Abecasis, G.R. and Boehnke, M. (2006) Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat. Genet., 38, 209-213.
42. U.S. Preventive Services Task Force. (2011) Screening for testicular cancer: U.S. Preventive Services Task Force reaffirmation recommendation statement. Ann. Intern. Med., 154, 483-486.
43. Lin, K. and Sharangpani, R. (2010) Screening for testicular cancer: an evidence review for the U.S. Preventive Services Task Force. Ann. Intern. Med., 53, 396-399.
44. Park, J.H., Wacholder, S., Gail, M.H., Peters, U., Jacobs, K.B., Chanock, S.J. and Chatterjee, N. (2010) Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat. Genet., 42, 570-575.
45. Lehrke, M., Millington, S.C., Lefterova, M., Cumaranatunge, R.G., Szapary, P., Wilensky, R., Rader, D.J., Lazar, M.A. and Reilly, M.P. (2007) CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans. J. Am. Coll. Cardiol., 49, 442-449.
46. McCarroll, S.A., Kuruvilla, F.G., Korn, J.M., Cawley, S., Nemesh, J., Wysoker, A., Shapero, M.H., de Bakker, P.I., Maller, J.B., Kirby, A. et al. (2008) Integrated detection and population-genetic analysis of SNPs and copy number variation. Nat. Genet., 40, 1166-1174.
47. The Wellcome Trust Case Control Consortium. (2007) Genome-wide association study of 14 000 cases of seven common diseases and 3,000 shared controls. Nature, 447, 661-678.
48. Starr, J.R., Chen, C., Doody, D.R., Hsu, L., Ricks, S., Weiss, N.S. and Schwartz, S.M. (2005) Risk of testicular germ cell cancer in relation to variation in maternal and offspring cytochrome p450 genes involved in catechol estrogen metabolism. Cancer Epidemiol. Biomarkers Prev., 14, 2183-2190.
49. Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M.A., Bender, D., Maller, J., Sklar, P., de Bakker, P.I., Daly, M.J. et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet., 81, 559-575.
50. Li, Y., Willer, C., Sanna, S. and Abecasis, G. (2009) Genotype imputation. Annu. Rev. Genomics Hum. Genet., 10, 387-406.
51. Li, Y., Willer, C.J., Ding, J., Scheet, P. and Abecasis, G.R. (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet. Epidemiol., 34, 816-834.
52. Marchini, J., Howie, B., Myers, S., McVean, G. and Donnelly, P. (2007) A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet., 39, 906-913.
53. Hosmer, D.W. and Lemeshow, S. (1992) Confidence interval estimation of interaction. Epidemiology, 3, 452-456.